细胞外矩阵捕获的生物灵感脂蛋白延长瘤的保留时间,以增强抗瘤免疫力
Yao Wu1,2, Yongping Li3, Zixin Hu4
1State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
Advanced materials (Deerfield Beach, Fla.)
|January 12, 2024
概括
这项研究引入了一种细胞外矩阵捕获的生物启发性脂蛋白 (FTF-BL-CP),用于增强免疫疗法的瘤保留. 这一策略显著提高T细胞激活和抗瘤免疫力,在乳腺癌模型中提供治疗效益.
科学领域:
- 生物医学工程 生物医学工程
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 在瘤中治疗剂的输送和保留仍然是有效的癌症免疫治疗的重大挑战.
- 瘤筋膜通常表现出高调的纤维素 (FN1) 和素C (TNC),为药物局部化提供了标.
研究的目的:
- 设计一种细胞外矩阵 (ECM) 捕获系统,用于长时间保留免疫调节剂的瘤.
- 评估该系统在增强抗瘤免疫力和临床前癌症模型中的治疗结果方面的有效性.
主要方法:
- 一个蛋白酶激活的FN1/TNC结合 (FTF) 与一个生物灵感的脂蛋白 (BL) 结合,形成FTF-BL-CP.
- FTF-BL-CP被设计为瘤ECM组件 (FN1/TNC) 的优先捕获,用于保留和响应释放.
- 免疫调节效应和治疗效益被评估在 ортотоп和肺转移性乳腺癌模型中.
主要成果:
- FTF-BL-CP治疗导致CD3+CD8+T细胞及其功能标记物 (干扰素-γ,花粉酶B,穿孔素,Ki67) 的显著增加.
- 治疗极大地引起了抗瘤免疫力,减缓了瘤生长,并在乳腺癌模型中延长了生存期.
- 观察到肺转移的抑制,突出显示了全身治疗潜力.
结论:
- 开发的ECM捕获策略有效地延长了瘤微环境中的药物保留时间.
- 这种方法显着有望增强抗瘤免疫力,改善抗癌免疫治疗结果.
- FTF-BL-CP代表了一种新且令人鼓舞的战略,用于克服癌症免疫治疗中的传递挑战.
更多相关视频
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527


